Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FL5YV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,708
Award facts
- Contract value 100% obligated
- $1,707.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded October 27, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $1,707.84 in firm fixed-price funding for the supply of Beyfortus 100 mg/ml syringes. The award represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract was competitively awarded with no set-aside designation, with performance scheduled for completion by October 28, 2025, and delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Beyfortus, a respiratory syncytial virus (RSV) monoclonal antibody immunization, represents a specialized pharmaceutical product critical to military healthcare operations. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen demonstrates established capability in delivering complex specialty medications and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and rapid completion timeline reflect standard DLA procurement practices for medical commodities supporting military personnel and beneficiaries across federal healthcare networks.
Quick answers
Who was awarded contract SPE2DB26FL5YV?
SPE2DB26FL5YV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FL5YV worth?
The government has obligated $1,708 on SPE2DB26FL5YV.
Is contract SPE2DB26FL5YV an order under another contract?
Yes. SPE2DB26FL5YV is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB26FL5YV competed?
The extent of competition for SPE2DB26FL5YV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award